Targeting the CD47-SIRPα Innate Immune Checkpoint to Potentiate Antibody Therapy in Cancer by Neutrophils
Leonie M. Behrens(Cancer Center Amsterdam), Marjolein van Egmond(Amsterdam Institute for Addiction Research)
Cited by 35
Related Papers
Augmented antibody-based anticancer therapeutics boost neutrophil cytotoxicity
|Journal of Clinical Investigation|2021|59
Antagonizing FcαR1 (CD89) as treatment in IgA-mediated chronic inflammation and autoimmunity
|Frontiers in Immunology|2023|12
Fcα Receptor-1-Activated Monocytes Promote B Lymphocyte Migration and IgA Isotype Switching
|International Journal of Molecular Sciences|2022|6